Orbital Sciences Corporation (NYSE:ORB – News) announced today that four of its executives are being promoted to new positions within the company. Mr. G. David Low, currently Vice President and head ...
Reduced doses of radiation were shown to be effective for some patients with indolent orbital B-cell lymphoma, researchers said. Ultralow-dose radiation therapy is an effective treatment strategy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback